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Abstract
Background: Access to free essential medicines is a critical component of universal health coverage. However
availability of essential medicines is poor in India with more than two-third of the people having limited or
no access. This has pushed up private out-of-pocket expenditure due to medicines. The states of Punjab and
Haryana are in the process of institutionalizing drug procurement models to provide uninterrupted access to
essential medicines free of cost in all public hospitals and health centres. We undertook this study to assess
the availability of medicines in public sector health facilities in the 2 states. Secondly, we also ascertained the
quality of storage and inventory management systems in health facilities.
Methods: The present study was carried out in 80 public health facilities across 12 districts in Haryana and
Punjab states. Overall, within each state 1 MC, 6 DHs, 11 CHCs and 22 PHCs were selected for the study. Drug
procurement mechanisms in both the states were studied through document reviews and in-depth interviews
with key stakeholders. Stock registers were reviewed to collect data on availability of a basket of essential
medicines −92 at Primary Health Centre (PHC) level, 132 at Community Health Centre (CHC) level and 160 at
tertiary care (District Hospital/Medical College) level. These essential medicines were selected based on the
Essential Medicine List (EML) of the Department of Health (DOH).
Results: Overall availability of medicines was 45.2 % and 51.1 % in Punjab and Haryana respectively. Availability
of anti-hypertensives was around 60 % in both the states whereas for anti-diabetics it was 44 % and 47 % in
Punjab and Haryana respectively. Atleast one drug in each of the categories including analgesic/antipyretic,
anti-helminthic, anti-spasmodic, anti-emetic, anti-hypertensive and uterotonics were nearly universally available
in public sector facilities. On the contrary, medicines such as thrombolytics, anti-cancer and endocrine
medicines were available in less than 30 % in public sector facilities. Among the medicines which were not
available at the time of survey in Haryana, nearly 60 % of them were out of stock for 3–6 months whereas
8 % of them were out of stock for more than 6 months.
Conclusion: Health system needs to be strengthened by making essential medicines available for patients.
Ensuring access to free medicines is likely to reduce private expenditure on medicines, which is a long-term,
sustainable way to towards universal health coverage in India.
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management, Universal health care
* Correspondence: shankarprinja@gmail.com
School of Public Health, Post Graduate Institute of Medical Education and
Research, Chandigarh 160012, India
© 2015 Prinja et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Prinja et al. BMC Pharmacology and Toxicology  (2015) 16:43 
DOI 10.1186/s40360-015-0043-8
Background
The provision of affordable, high quality and appropriate
essential medicines is a vital component of a well-
functioning health system. Nearly 10 million lives could
be saved by improved access to essential medicines, of
which 4 million are in Africa and South-East Asia alone
[1]. However, providing universal access to essential medi-
cines is a major challenge in low and middle income
countries (LMICs) [2]. Although there is reasonably suffi-
cient information from the developed nations regarding
access to essential medicines, the data from LMICs is
often weak and fragmented.1Recent studies report that in
LMICs the average availability of medicines in the public
sector is only 35 % [3]. According to a World Health
Organization (WHO) report, almost 68 % of the people in
India have limited or no access to essential medicines [2].
Poor availability of medicines in the public sector has
pushed up household out-of-pocket (OOP) expenditure,
making them the largest household expenditure item
after food [4]. Up to 90 % of the population in develop-
ing countries purchase medicines through OOP pay-
ments [5]. Nearly 80 per cent of India’s health care
expenditure is borne by patients OOP, of which medi-
cines constitute 70 % [6]. Another study in the three
North Indian states of Haryana, Punjab and Chandigarh
also reported that medicines constituted 19-47 % of
hospitalization expenditure and 59 to 86 per cent out-
patient department (OPD) expenditure borne out-of-
pocket by households in public sector [7].
Access to free of cost essential medicines is a critical
component of universal health coverage. This is being
considered as a key intervention in Government of
India’s (GOI) proposed National Health Assurance
Mission (NHAM) in 2014 [8]. Ensuring availability of
free essential medicines significantly reduces the burden
on private OOP expenditures. Moreover, it provides
financial risk protection to population, most vulnerable
to pay catastrophic health expenditures [9]. Every Indian
state follow an independent mechanism of procurement
of medicines. Various drug procurement models have
been implemented in states like Tamil Nadu, Kerala and
Rajasthan towards achieving the goals of universal health
coverage. This has resulted in lower price and better
availability of medicines through efficient supply chain
management [10, 11]. Tamil Nadu follows a mixed
procurement system (80 % centralized and 20 % decen-
tralized) whereas in Kerala it is completely centralized,
for acquiring medicines. Moreover, the procurement
systems in both the states are completely autonomous
with minimal interference of state government. The
governance structures created in the two states (Punjab
and Haryana) are also very similar to the models followed
in Kerala and Tamil Nadu. This has also led to similar
processes being followed for inviting the suppliers, pricing,
selection of essential medicines, setting up of distribution
channels etc. [10]. Other State Governments in India are
planning to replicate such models to provide essential
medicines free of cost at all public health facilities.
The current study is a comprehensive effort to assess
the availability of medicines in public sector health facil-
ities in two North Indian states of Punjab and Haryana.
Both the states have recently instituted procurement
mechanisms similar to states like Tamil Nadu and Kerala
to provide uninterrupted access to essential medicines of
good quality and free of cost in all government institu-
tions [10, 12]. This study reflects the baseline situation
on availability of medicines prior to setting up of new
procurement systems. This evidence not only reflects on
the baseline situation but will also serve as a reference
to evaluate the impact of new systems of procurement
and their cost effectiveness. In this paper, we report the
availability of essential medicines at various levels in
public health facilities in Haryana and Punjab. Addition-
ally, we also assessed the storage and inventory systems
of medicines in the public health facilities. As a part of
large study, the system of procurement, pricing and
distribution was also reviewed.
Methods
Study setting and sampling
The state of Haryana is one of the wealthier states of
India with the third highest per capita income in the
country in the year 2012–13 [13]. Nearly two-thirds of
the 25 million population of the state resides in rural
areas [14]. Punjab is another prosperous agricultural
state with a population of 28 million with similar
proportion belonging to rural areas [15]. As in rest of
India, a 3 tier health care service delivery system caters
to needs of population in Haryana and Punjab. The
primary level includes Sub-centres (SCs) and Primary
Health Centres (PHCs). The Community Health Centres
(CHCs) and District Hospitals make up the secondary
level, and the Medical Colleges are at the tertiary level.
The Sub-centre (SC) is the most peripheral health
institution for every 5000 population. SC is staffed by
an Auxiliary Nurse Midwife (ANM). Primary Health
Centres (PHCs) which are manned by medical officer
(doctor) provide primary care to a population of around
30000.Community Health Centres (CHCs) provide sec-
ondary care services to a population of around 1, 20,000.
District Hospitals (DHs) provide specialist secondary care
facilities at the district level whereas Medical colleges
(MCs) provide tertiary care services.
A multi-stage stratified random sampling was followed
for district selection. In the first stage, all districts were
stratified in three categories based on the human devel-
opment score, i.e. high, medium and low status of
development [16]. Secondly, 2 districts were selected
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randomly from each strata. The selected set of districts
also ensured a geographical representation of the state.
In second stage, a total of 80 public health facilities
were chosen for the study so as to cover all levels of
health care delivery system, i.e. primary, secondary and
the tertiary. The study sample included 1 medical college
from each state and 1 district hospital (DH) in each
district. We selected almost 30 % of CHCs in each
district and two PHCs under each CHC were randomly
selected. Overall, within each state1 MC, 6 DHs, 11
CHCs and 22 PHCs were selected for the study. The
final sample thus comprised of 2 tertiary care medical
colleges, 12 district hospitals, 22 CHCs and 44 PHCs for
the two states. The details regarding the sampled public
health facilities are given in Table 1.
Data collection
Primary data collection was undertaken to meet the
objective of the study in the period of June to July
month of year 2013. Primary data included assessment
of availability of medicines, storage, inventory manage-
ment and stock-outs at facility at different level of
facilities in sample districts of 2 states.
For assessing availability and stock-outs of essential
medicines at the facility, the ‘Facility Level Medicine Avail-
ability and Stock-out Tool’ was used (Additional file 1:
Table S1). The tool was used to collect data on drug
availability on the day of the survey, medicine stock-out
position for the previous six months from the date of the
survey and the duration of stock-outs. A team of trained
investigators visited pharmacy outlets at public health
facilities with survey tools to capture availability and
stock-outs of medicines. The investigators were post-
graduates with previous experience of social sciences
research in health system. Moreover, one member of
the team who collected the data was a medical officer.
A one week training was undertaken for field investiga-
tors to train them on data collection methods, tools,
familiarization of drug procurement and management
at facility level. They carried out structured interviews
with the store-in-charge/medical officer/pharmacist/
any other person handling procurement and dispensing
at the facility level. Data was extracted from stock
registers available in each facility. A list of medicines to
be surveyed was prepared after reviewing the National
List of Essential medicines (NLEM), state Essential
Medicine List (EML), and medicines provided under
National Health Programs. Availability of medicines
were assessed at primary, secondary and tertiary health
facilities against the basket of 92, 132 and 160 medi-
cines respectively selected according to therapeutic
categories. In addition to the medicines under primary
care facilities, secondary care facilities had 40 other
medicines, whereas, in addition to the medicines under
the primary and secondary care facilities, tertiary care
facilities had 28 other medicines belonging to categories
such as anti-cancer medicines, hormonal supplements,
certain antibiotics like cefixime, vancomycin and other
medicines like allopurinol, urokinase, glucagon, lithium
carbonate etc. The list of medicines has been given as
an appendix. A structured tool was used to collect data on
stock-out and availability of survey medicines in public
health facilities. Ten percent of medicines available as per
records were randomly cross-checked in the store. For the
medicines not available on the day of the survey, the
number of days of stock outs in last 6 months was
recorded by manual checking of stock registers.
Additionally as a part of overall study, data on
structures of procurement system, distribution and
pricing was collected, although, in this paper we
limited our focus only on availability of medicines in
two states.
Data analysis
Data was entered in Microsoft Access 2010, and
analysed using SPSS version 21.Two types of analyses
were done to assess the availability of medicines. In
first analysis, availability of all the medicines under a
particular therapeutic category was assessed, whereas
in second analysis, even a single drug (out of total
medicines under each therapeutic category) available
under a therapeutic category was considered as avail-
ability of that particular therapeutic category. Both the
type of analysis are explained below:
Table 1 Summary of the sample of public health facilities selected
Characteristics Total Sample selected % of Total
Districts 43 12 27.9
District Hospital (1 from each selected district) 43 12 27.9
CHCs (30 % of CHCs in the selected districts) 241 22 9.13
PHCs (2 from each CHC) 896 44 4.91
Medical College (1 from each state) 6 2 33.3
Total Public Facilities Sampled 1186 80 6.75
Note: Source: For information on total number of public health facilities - Rural Health Statistics 2012, Ministry of Health and Family Welfare, Government of India – Accessed
on 18/05/2014, PHC = Primary Health Centre, CHC = Community Health Centre
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Availability of medicines by therapeutic category
The medicines were classified into therapeutic categories.
A drug was considered available if it was in stock on the
day of the survey. Availability of a therapeutic category in
a facility is explained by the formula: (n/N) * 100, where n
is the number of medicines available within that category
in a facility on the day of the survey and N is the total
number of medicines within that category that should be
available as per the list of medicines prepared. For a
particular level of facility (say for example PHC level in
Punjab), overall availability of a particular category of




Where, ni is the number of medicines available within
a therapeutic category in a particular facility and M is
the number of facilities in that particular level of care (in
this case, 22 PHCs were surveyed in Punjab) and N is
the total number of medicines within that category that
should be available as per the list of medicines being
surveyed. Thus N*M gives the total number of medi-
cines in that category that were surveyed in all PHCs in
Punjab. As an example, if 6 (N) antihypertensive medi-
cines were evaluated for availability in 22 PHCs (M) of
Punjab, then a total of 132 items (M*N) are being evalu-
ated. Against a set of these items, if 4 antihypertensive
drugs are available in 12 facilities and 3 antihypertensive
medicines are available in remaining 10 facilities, then
the overall anti-hypertensive medicine availability at
PHC level in Punjab is 59 % [((4*12) + (3*10))*100/132].
Overall availability of a particular category of medicine
across all levels of care in a state is given by the formula:
X
nið Þ  100X
Mi Ni
i ranges from 1–4, where 1,2,3,4 stands for four levels
of care namely PHC, CHC, DH and MC.
Where, ni is the number of medicines available within
a therapeutic category in a particular facility and Mi is
the number of facilities in that particular level of care
and Ni is the total number of medicines within that
category that should be available as per the basket of
medicines in that particular level of care.
Each dosage form of medicine was considered as a
separate entity in the basket of medicines. This was in
concordance with the way it is required as per the
Essential Drug List in India. It is also justified theoretic-
ally, as each of these medicines in the specific dosage
form should be available for dispensing at the health
facility. In another analysis, a particular category of drug
was considered available when at least one drug from
the category was available. Average duration of stock out
was computed for those medicines which were not
available on the day of survey. We categorized stock out
duration as less than 1 month, 1–3 months, 3–6 months
and more than 6 months.
Ethical approval
This study was approved by ethics committee of Post
Graduate Institute of Medical Education and Research
(PGIMER), Chandigarh (India). Approval was obtained
from concerned authorities of health departments in
both the states. Prior to data collection, administrative
approval for carrying out the study was taken from the
Civil Surgeon (head of health administration) at the
district level in all 12 districts. Written informed consent
of the chief pharmacist and medical officer (MO) was
sought prior to the interviews and review of records.
This study was funded by the Public Health Foundation
of India (PHFI), New Delhi.
Results
Storage and inventory management system of medicines
Around 95 % of public health facilities in Punjab had the
dedicated storage space with temperature control and
proper ventilation. Cold storage facility was available in
85 % of facilities in Punjab. All the public health facilities
in Haryana had the dedicated space for storage along
with cold storage facility for medicines. Around 89 %
had temperature control mechanism and proper ventila-
tion in Haryana. Medicines were stored directly on floor
in Punjab and Haryana in 28 % and 18 % of public
health facilities respectively. Evidence of pests in drug
stores were found in 10 % of facilities in Haryana
whereas it was only 2 % for Punjab.
All the public health facilities (40) in Punjab and 37
(93 %) health facilities in Haryana were found to main-
tain scientific inventory management method of First
Expiry First Out (FEFO) (Table 2). At the PHC level, the
average interval of indenting the medicines was 96 days
in Punjab, whereas it was only 37 days in Haryana. At
the district level, the average indenting interval was 26
and 45 days in Punjab and Haryana respectively. At the
PHC level in Punjab, it took more than three weeks
(25 days) for the medicines to reach the facility after
indenting, whereas in Haryana it took only 7 days. At the
CHC level it took around 2 weeks for the medicines to
reach the facility in both the states. The average duration
to receive medicines at district hospital was 17 days and
49 days in Punjab and Haryana respectively (Table 2).
Availability of essential medicines at public health
facilities by therapeutic category
Overall availability of medicines in Punjab was 45.2 %
which varied from 48 % at the DH and PHC to 44 % at
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CHC level (Table 3). The availability of medicines at a
MC was only 4.4 %. In Punjab, almost 70 % of public
health facilities had the medicines in categories of ant-
helminthic/anti-parasitic, antispasmodic, antiemetic and
uterotonics available at the time of survey. However,
anti-cancer, thrombolytics and endocrine related med-
icines were available in less than 10 % of facilities. At
the PHC level, the availability of anti-hypertensives
was 60%whereas only around one-third of PHCs had
anti-diabetics, antidepressants/antipsychotics and anti-
asthmatics available on day of survey. At the DH,
availability of anti-diabetics, NSAID, anti-allergic and
anti-hypertensives was more than60%. In the medical
college in Punjab, apart from some anti-bacterials, anti-
cancer agents and anaesthetic medicines other essential
medicines were found out of stock (Table 3).We also
assessed the availability of medicines considering if any of
the drug falling under a therapeutic category is available at
Table 2 Inventory Management Process in Public Health Facilities of two North Indian States
Inventory management process Punjab Haryana
PHC n = 22 CHC n = 11 DH n = 6 MC n = 1 PHC n = 22 CHC n = 11 DH n = 6 MC n = 1
Methods of Inventory management (FEFO) 22 11 6 1 20 11 5 1
Methods of Inventory management (FIFO) 0 0 0 0 2 0 1 0
Average interval of indenting (days) 96 39 26 NR 37 42 45 NR
Average numbers of medicines indented 50 115 99 NR 63 69 166 NR
Average number of medicines received per indent 71 90 NR NR 79 84 50 NR
Average number of days to receive medicines 25 16 17 NR 7 15 49 NR
PHC = Primary Health Centre; CHC = Community Health Centre; DH = District Hospital; MC =Medical College; NR = Not recorded;
FEFO = First-Expiry-First-Out; FIFO = First-In-First-Out
Table 3 Availability of Medicines (%) by Therapeutic Category in Public Health Facilities
Drug category Punjab Haryana
PHC CHC DH MC Total PHC CHC DH MC Total
Analgesic/Anti-Pyretic/NSAID 74.3 49.1 61.1 0 58.7 70.0 43.6 47.2 33.3 53.6
Anti-bacterial 50.8 52.5 54.2 12.5 50.7 59.1 59.8 59.7 62.5 59.6
Anti-allergic 49.6 58.3 63.9 8.3 53.4 59.7 62.0 66.2 75.0 61.8
Vitamins & Minerals 53.7 46.5 50.0 0 49.2 60.4 60.6 68.5 44.4 61.4
Anti-asthmatic 31.0 36.4 47.2 0 34.2 50.0 54.5 72.2 50.0 54.6
Antacid 42.9 41.2 40.5 0 40.0 71.2 66.7 69.0 71.4 69.1
Anti-helminthic/Anti-parasitic 90.5 68.2 70.8 0 77.0 54.5 72.7 66.7 75.0 63.0
Anti-fungal 0.0 31.8 50.0 0 36.1 0.0 50.0 41.7 50.0 47.2
Anti-spasmodic 71.4 68.2 75.0 0 69.2 63.6 63.6 75.0 0.0 63.8
Anti-emetic 90.5 90.9 100.0 0 89.7 77.3 77.3 66.7 100.0 76.3
ORS 61.9 54.5 83.3 0 61.5 100.0 100.0 100.0 100.0 100.0
Anti-hypertensive 60.5 61.4 61.7 0 59.1 59.7 58.6 55.0 60.0 58.5
Anti-diabetic 35.2 54.5 63.3 0 44.1 38.2 49.1 76.7 40.0 47.0
Thrombolytic 0.0 4.3 20.0 0 9.9 0.0 10.2 46.7 50.0 26.6
Antidepressant/Anti-psychotic/Antiepileptic 31.9 30.1 41.7 0 32.2 27.7 34.1 47.6 64.3 34.4
Anti-viral 0.0 29.2 33.3 0 28.9 0.0 13.6 27.8 0.0 18.6
Uterotonics 88.1 83.8 63.3 0 76.3 68.2 66.7 66.7 80.0 67.9
Other endocrine medicines 9.5 2.4 4.8 0 5.9 13.6 21.2 28.6 14.3 19.6
Miscellaneous 34.9 34.5 38.2 5.9 34.4 35.4 39.4 37.3 23.5 36.5
Anti-cancer medicines 0.0 0.0 4.2 25 4.4 0.0 9.1 4.2 25.0 7.7
Anaesthetic agents 28.6 34.1 45.8 25 32.7 27.3 29.5 66.7 50.0 34.4
Total 48.1 44.0 47.8 4.4 45.2 50.9 49.3 54.1 50.6 51.1
Note: Figures given in the table are percentages. Overall, 2 MC, 12 DH, 22 CHC and 44 PHC were covered in this study in the two states Punjab and Haryana.
Where; PHC = Primary Health Centre, CHC = Community Health Centre, DH = District Hospital, MC =Medical College
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the time of survey. Only 5 % facilities had a single drug
in anti-cancer category whereas any thrombolytic,
endocrine, anti-fungal and anti-viral drug was available
in 23 %, 25 %, 30 % and 35 % of public health facilities
respectively (Table 4).
In Haryana, the overall availability of medicines was
51.1 % with highest at DH level (54.1 %) followed by PHC
(50.9 %), MC (50.6 %) and CHC (49.3 %). In Haryana,
overall drug availability in public health facilities was good
(almost 70 %) in categories like antiemetic, antacid and
uterotonics whereas poor (less than 30 %) in therapeutic
categories such as anticancer, antiviral, endocrine and
thrombolytics. Less than 40 % of the PHCs had anti-
diabetics and anti-depressant/anti-epileptic available
on the day of survey. Availability of anti-asthmatics,
anti-allergics, antacids, anti-diabetics, anti-spasmodic
and anti-emetics was more than two-third at the DH
level (Table 3). Among the anti-bacterials, anti-diabetics,
anti-hypertensives, anti-asthmatics, anti-depressants/
anti-psychotics, vitamins and antacids, at least one
drug from each category was present in almost all the
public health facilities. However, not even a single
drug among therapeutic categories like anti-cancer,
anti-viral, thrombolytics and endocrine medicines was
present in around 95 %, 65 %, 77 % and 75 % of health
facilities of Punjab respectively and; 92 %, 80 %, 67 %
and 52 % of health facilities of Haryana respectively
(Table 4).
Stock-outs of essential medicines
Among the medicines which were not available at the time
of survey in Haryana, nearly 60 % of them were out of stock
for 3–6 months whereas 8 % of them were out of stock for
more than 6 months (Fig. 1). Nearly 60 % of analgesics,
anti-allergics, anti-spasmodics, anti-hypertensives, ant-
acids and vitamins, which were not available at the time
of survey, were out of stock for the last 3–6 months.
Among the anti-diabetics not available, 75 % were out
of stock for 3–6 months (Fig. 1).Average number of
days of stock out for analgesics, anti-bacterial, anti-
helminthic, anti-fungal, anti-diabetic and uterotonics
was 160–180 days.
Table 4 Availability of Medicines (any one drug available within the therapeutic Category) by Therapeutic Category at different level
of public health facilities
Drug category Punjab Haryana
PHC CHC DH MC Total PHC CHC DH MC Total
Analgesic/Anti-Pyretic/NSAID 100 100 100 0 98 100 100 100 100 100
Anti-bacterial 100 100 100 100 100 100 100 100 100 100
Anti-allergic 100 100 100 100 100 100 100 100 100 100
Vitamins& Minerals 100 100 100 0 98 100 100 100 100 100
Anti-asthmatic 95 100 100 0 95 86 100 100 100 93
Antacid 95 100 100 0 95 91 100 100 100 95
Anti-helminthic/Anti-parasitic 95 100 100 0 95 95 100 100 100 98
Anti-fungal 0 64 83 0 30 0 100 83 100 43
Anti-spasmodic 91 82 100 0 88 91 100 100 0 93
Anti-emetic 95 91 100 0 93 91 91 83 100 90
ORS 64 64 83 0 65 100 100 100 100 100
Anti-hypertensive 100 100 100 0 98 100 100 100 100 100
Anti-diabetic 100 100 100 0 98 91 100 100 100 95
Thrombolytic 5 27 83 0 23 0 55 100 100 33
Anti-depressants/Antipsychotics 100 100 100 0 98 100 100 100 100 100
Anti-viral 0 73 100 0 35 0 27 83 0 20
Uterotonics 91 100 83 0 90 86 100 100 100 93
Endocrine medicines 32 18 17 0 25 32 55 83 100 48
Miscellaneous 100 100 100 100 100 100 100 100 100 100
Anti-cancer medicines 0 0 17 100 5 0 9 17 100 8
Anaesthetic agents 95 100 100 100 98 73 82 100 100 80
Total 74 82 89 24 77 73 87 93 90 80
Note: Figures given in the table are percentages. Overall, 2 MC, 12 DH, 22 CHC and 44 PHC were covered in this study in the two states Punjab and Haryana.
Where; PHC = Primary Health Centre, CHC = Community Health Centre, DH = District Hospital, MC =Medical College
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In Punjab, among the medicines which were not available
at the time of survey, nearly 40 % of them were out of stock
for 3–6 months whereas 19 % of them were out of stock
for more than 6 months. About 27 % of anti-hypertensives
and 19 % of anti-diabetics were found to be out of stock for
more than 6 months (Fig. 2). Average number of days of
stock out for analgesics, endocrine, anti-asthmatic and anti-
helminthic medicines was 231 days, 211 days, 193 days and
186 days respectively.
Drug procurement models in Haryana and Punjab
In Haryana, there are three main sources of funding for
the procurement of essential medicines. Firstly, the State
Government provides funds in its budget for purchase
of medicines. Secondly a grant-in-aid received from the
Government of India as part of its flagship program
National Health Mission (NHM) comprises of a budget-
line for medicines. Finally, the untied funds available
with the health facility committee can be used for
purchasing medicines with a minor contribution comes
from the money collected as a part of user charges. In
decentralized system under National Health Mission
(NHM), untied funds are given to health facilities which
can be used to improve the quality of care. One of these
activities on which untied funds can be used is purchase
of essential medicines. In 2011–12, total budget for
Fig. 1 Duration of Stock out (For medicines not available at the time of survey) in public health facilities, Haryana
Fig. 2 Duration of Stock out (For medicines not available at the time of survey) in public health facilities, Punjab
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medicines in Haryana was INR 350 million, out of which
the contribution from NHM and State Government is
43 % and 57 % respectively. The procurement and distri-
bution model for medicines followed in Haryana was set
up in 2009. In this system, procurement of medicines
was decentralized at district level. A task committee was
formulated at state level comprising of experts including
pharmacologists, state drug controller and other health
system program managers who reviewed the State EML
every year.
In this procurement system, funds were disposed to
District Health Societies for the procurement of medicines
& consumables. As per the procurement policy, all medi-
cines and medical consumables were to be purchased
under Pharmacopoeia generic names. Medicines listed in
the EML, were called through open tendering at district
level. Open tendering system is a process in which quota-
tions are invited from potential manufactures or suppliers
(mainly pharmaceutical firms) by authorities (generally
Director Supplies and Disposal) through a proper channel.
Only firm (i.e. Pharmaceutical manufacturers and sup-
pliers) which had Good Manufacturing Practices (GMP)
Certificate in accordance with the WHO recommenda-
tions issued by Central / State Drug Control Authorities
were eligible. Two or three firms (L1, L2, L3) were
approved for each drug with a validity of two years.
Random samples of medicines from each consignment of
medicines were tested at government approved laborator-
ies. Sample which did not meet quality standards were
rejected entirely and costs were recovered from the firm.
A proper channel was followed between health facilities
and District Health Societies for distribution of procured
medicines. The frequency of issuing indents for obtaining
medicines from district store was used for assessment,
forwarded by Chief Pharmacist. Distribution of medicines
was done to all level of facilities after assessing the indent
against previous demand and utilization pattern. Every
health facility has been issued a passbook, in which all the
records related to demands through indents, stock-out
and utilization status of medicines are maintained. When
a facility raise its demand through indent, these pass
books are analyzed and serve as a useful tool for assess-
ments. ‘Demand’ for medicines implies a manifestation of
medicine requirement in the form of an ‘indent’ which a
health facility puts up to the local warehouse or supplier
of medicine, for provision of the same.
Similar to Haryana, Punjab also had decentralized
procurement system. For procurement of medicines in
Punjab the districts placed their orders to State. Medicine
budget was released from state to district dependent upon
demand raised by district. Majority of the procurement
was done at district level utilizing these funds except few
medicines which were directly procured by State. All the
facilities retained the revenue generated in the form of
user charges. Almost 40-45 % of revenue generated at
facility level against user fee charges was also utilized for
medicine purchase. Only emergency medicines which are
not available at state/district level stores or not approved
to be part of EML, can be purchased through this route
under the name of ‘local purchase’. Almost every district
had their dedicated drug stores. The tenders of medicines
were floated at district level. Medicines are purchased in
bulk at state level. This is a paradigm shift from the
past, where medicine procurement happened at the
district level. For medicines which could not be purchased
through tendering process due to reasons like non-
participation in bidding from firms, the state empa-
nelled chemist shops from which health facilities
could purchase medicines directly at fixed prices. In
such cases, medicines are purchased from chemists
with some discount (from their profit margin) on
market price.Adherence to procurement guidelines
was poor in the decentralized system. Alike Haryana,
indenting of medicines at facilities was done through
pharmacists and supply obtained from district level.
Discussion
Availability of free essential medicines is critical to deliver
universal health care. Lack of access to medicines causes
households to face financial catastrophe through increased
OOP expenditure [17]. Health spending in India was 4 %
of Gross Domestic Product (GDP) in the year 2012 with
public share being one-third only [6]. Out-of-pocket
expenditure persists to be major source of health spending
out of which almost 70 % of the OOP burden is caused
due to medicine expenses [6, 7, 18]. OOP on medicines
alone pushes 2.2 % of the population below the poverty
line annually [19]. Unavailability of medicines is also the
major reason for dissatisfaction among patients [20]. Be-
sides that, lack of supplies impacts upon staff morale
through community pressure [21]. We found that the
overall availability of essential medicines in public
sector health facilities and hospitals was 45.2 % and
51.1 % in Punjab and Haryana respectively which is
well below the WHO standards of 80 %. Similar levels
of drug availability were also reported from studies in
other low-middle-income countries [3, 22, 23].
Recent surveys in India show significant variation in
the availability of essential medicines in different states.
The mean availability of a selected basket of essential
medicines in Bihar was 43 % as compared to 88 % in
Tamil Nadu [24]. Another study in Delhi reported mean
availability to be 41 % and 23 % in facilities under State
government and Municipal Corporation respectively
[25]. Surveys carried out in six states in India using a
standard WHO methodology reported poor availability
of medicines in the public sector with median availability
ranging from 0–30 % [26]. Analysis of National Sample
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Surveys showed that during the mid-1980s one-third of
medicines during hospitalization were supplied free of
cost which declined to 9 % during 2004. In case of
outpatient care, free medicine supply declined from 18 %
to about 5 % over the same period [27]. Low availability of
essential medicines at public health facilities force patients
to purchase medicines from private pharmacies where
there is higher availability of medicines and for many
medicines, only one brand of the product is available
usually the costly one [25]. Therefore, the patients have no
choice but to buy that particular costly branded product
thereby incurring catastrophic drug expenditure.
We found that most of the facilities followed a scientific
method of inventory management (FEFO). However, the
average number of days needed to receive the medicines
varied from 4 to 14 weeks in a public sector facility which
might explain frequent stock-outs and thus pointing to
the inefficiencies in the procurement/distribution system.
Low availability of medicines in the public sector and
frequent stock-outs has also been reported in other
studies due to factors such as under-funding, inaccurate
forecasting, inefficient procurement/distribution mechan-
ism in the supply chain, prescription practices leading to
prescriptions for medicines outside the public health
system and the notion that medicines supplied through
the public system are of low quality [3].
Non-communicable diseases require long-term com-
pliance to treatment sometimes even for a lifetime.
With the rising burden of non-communicable diseases,
poor availability of anti-hypertensives, anti-diabetics,
anti-asthmatics and anti-depressants/anti-psychotics, as
reported in the present study, force patients to pur-
chase medicines from the private sector or forego treat-
ment if they cannot afford it. Another study also
reported poor availability of essential medicines for
chronic diseases in six LMICs in public sector but
better availability in the private sector [28].
Various recommendations to improve availability of
essential medicines in the public sector are proposed in
the literature such as – increase the budget for medi-
cines; formulate standard treatment guidelines (STGs)
and EML based on STGs; separate EML for primary care
and other levels of care; procurement and distribution of
medicines based on EML; procurement by generic name;
efficient transparent and accountable procurement and
distribution system; use of robust IT systems; utilizing
local supply options; supportive legislation and regula-
tion; better prescription practices; and regular monitor-
ing and evaluation of the system [28–30].
Different procurement models centralized, decentralized
and mixed have been tried in India. A review of literature
reports that autonomous centralized procurement organi-
zations such as in Tamil Nadu and Kerala were more
efficient in relation to payments to suppliers, had relatively
lower drug procurement prices and managed the inven-
tory more scientifically [10]. Many states are now trying to
replicate the Tamil Nadu Medical Services Corporation
(TNMSC) model of centralized tendering and purchase of
medicines. However, critical success factors of each model
need to be carefully analysed to see if they are valid in
another state context before replicating them. The key
factor for the success of TNMSC is its autonomy coupled
with able leadership. Besides, for centralized procure-
ment models it is necessary to have optimum number
of warehouses, adequate transportation facilities to
transfer supplies from warehouses to user facilities, a
robust IT system for real-time monitoring of stocks
and online ordering and dispensing, which requires
considerable amount of capital expenditure. Despite
implementing similar reforms, the state of Odisha did
not garner similar level of success as in Tamil Nadu.
With poor autonomy of the drug procurement agency,
Odisha grappled with implicit state level problems of
poor governance, lack of political will and ineffective
leadership. Thus, Odisha, with poor infrastructure,
insufficient investment and inherent system related
problems has failed to reap the benefits of a centralized
pooled procurement model [10]. There are some success-
ful models as well. The pooled procurement system intro-
duced in Delhi along with carefully selected essential
medicine list, standard treatment guidelines and focus on
rational prescribing has resulted in uninterrupted supply
of good quality medicines and has brought down the
procurement costs of medicines saving nearly 30 % of the
annual medicines bill which were mobilized for procuring
more medicines. This in turn improved availability of
medicines (more than 80 %) at health facilities [31].
We acknowledge that evaluating availability of basket of
medicines at overall level or by the therapeutic category,
between and within sectors, or between the states may not
be the most relevant. In order to circumvent this problem,
we have revised our analysis (Additional file 2: Table S2),
in terms of availability of each and every medicine
within each therapeutic category. Nonetheless, asses-
sing the availability for the pool “basket of medicines”
is also relevant from policy perspective as all the
medicines which are part of the surveyed basket of
medicines, constitute part of the essential drug list in
India. As a result, none of the medicines being surveyed
are non-essential or non-recommended.
Governance in procurement process plays a critical
element for optimum utilization of resources in public
health system, given the technical complexity of drug
procurement. A transparent, efficient and cost-effective
procurement process is desirable. The procurement
organizations in Tamil Nadu, Rajasthan and Kerala are
autonomous. The idea of having an autonomous cor-
poration for procurement and distribution of medicines
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is to enable it to function more transparently by avoid-
ing the plausible procedural delays and make quick
decisions for better functioning of the organization. It
also has an advantage of economies of scale wherein there
is better negotiation with the suppliers. States such as
Uttar Pradesh, Bihar, Gujarat and many others have
Central Medical Stores Department under Department of
Health and Family Welfare responsible for procurement
of medicines and other medical supplies. But the role of
this department is limited up to finalization of rate
contract with suppliers. Actual procurement is carried
out at district levels by Chief Medical Officers at district
level or through head of health facilities at district and
sub-district level.
Punjab and Haryana have procurement cells that are a
part of the state health services which may have a bearing
on the efficiency of the processes. They are in a transition
to adopt centralized procurement and decentralized
distribution model. In Punjab, a robust IT system needs
to be integrated into the procurement mechanism to
enable tendering process and real-time inventory con-
trol. Although both the states have mandated prescrip-
tion by generic names and adherence to Standard
Treatment Guidelines (STGs), implementation is poor
which requires strict monitoring and supervision by an
independent agency.
However there are certain limitations to this study.
Most importantly, in this paper we report the availability
of medicines in the public health facilities. However, a
more comprehensive assessment of the accessibility of
essential medicines would also encompass issues related
to selection, procurement, distribution and prescription
of medicines. While, for the overall study we did under-
take prescription audits, the same is not reported here.
Moreover, issues related to pricing of medicines and its
regulation, and market competition among the suppliers
has not been considered which are recommended as
potentially important research questions. Secondly, we
present a description of the systems for procurement
and distribution system, but the same has not been
critically evaluated as it is still the early formative
period of transition in terms of procurement and distri-
bution system in both these states. Thirdly, for sake of
consistency, availability was determined for a specific
list of survey medicines in both the states. The medi-
cines were part of the Essential Drug Lists (EDLs) in
the two states, but do not include all medicines in the
list. Nevertheless, the medicines surveyed as part of the
study comprised of more than 50 % EDL medicines in
both the states. Differences in quality across products
was not accounted for. Lastly, our study did not employ
WHO/Health Action International (HAI) methodology
for assessing the availability of medicines which is used
by several studies done in India.
We recommend similar analysis of availability of medi-
cines in the private sector. It is also recommended to
study the medicine prices across private sector providers
and level of price competition in pharmaceutical market.
More future research is recommended to critically
analyse the various models of centralized procurement
and decentralized distribution systems in various states
across India, to determine the factors which improves
the access to medicines.
Conclusion
Strengthening the public sector availability of medicines
is a long-term, sustainable way to reduce private expend-
iture on healthcare. Increased allocation of funds on
medicines is of paramount importance. Robust IT sys-
tems should be used for scientific warehousing and
inventory management, real-time stock monitoring and
transparent centralised procurement and decentralised
distribution mechanism. State governments should
evaluate their procurement systems to ensure efficiencies
and make necessary reforms to improve availability. The
data from present study can be used as a baseline to
evaluate the effectiveness and cost-effectiveness of the
interventions being undertaken in Punjab and Haryana
to establish robust centralised procurement and decen-
tralised distribution systems for medicines.
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